Through this RFP we aim to support research studies, either original research or reviews of published literature, that aim to enhance the diversity of postmarketing drug safety surveillance programs. Specifically, Proposals should focus on identifying, quantifying, and defining potential disparities in the safety and effectiveness of medications, vaccines, and medical devices across diverse populations. 

Project Types and Area of Interest
The objective of this RFP is to improve the quality of postmarketing drug safety surveillance programs by incorporating diverse perspectives, data sources, help improve the overall quality of healthcare, and promote health equity.  

We are particularly interested in research involving populations who are at greatest risk due to disparities and social determinants of health. This may include projects that address the effect that structural barriers (e.g., access), social determinants (e.g., racial and ethnic inequities, geography, economics, health literacy, history), and attitudes (e.g., fear, trust) have on postmarketing drug safety surveillance diversity. 

See more details